(CIDRAP News) A report that paved the way for the World Health Organization's (WHO's) recent recommendation to keep intact the two known collections of smallpox virus cites a wide range of ongoing research on smallpox, including genome sequencing, molecular diagnostic techniques, antiviral drugs, and new vaccines.
(CIDRAP News) The world's last naturally acquired case of smallpox occurred almost exactly 25 years ago, the Centers for Disease Control and Prevention (CDC) notes in today's issue of Morbidity and Mortality Weekly Report.
The smallpox case occurred in the Merca District of Somalia on Oct 26, 1977, the CDC says. Less than 3 years later, in May 1980, the World Health Organization declared the world free of naturally occurring smallpox.
(CIDRAP News) – The CIA has good evidence that four nations—Iraq, North Korea, Russia, and France—have secret stores of smallpox virus, according to a Washington Post report based on comments from officials speaking anonymously.
(CIDRAP News) An influenza virusespecially one genetically manipulated for increased virulencewould be an attractive weapon for bioterrorists, according to physicians writing in the Journal of the Royal Society of Medicine.
(CIDRAP News) – The World Health Organization's (WHO's) plan to build an international emergency stockpile of smallpox vaccine drew support from member countries at their recent annual meeting in Geneva.
The World Health Assembly (WHA) "welcomed progress on WHO's work to establish a global smallpox vaccine reserve," the WHO said in a statement during the meeting, which ended last week.
(CIDRAP News) – A second-generation smallpox vaccine made by the British biotechnology company Acambis plc and stockpiled by the US government as protection against bioterrorist attacks has been approved by the US Food and Drug Administration (FDA).
(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.